Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Oct 2015

Kim Jaegil, Akbani Rehan, Creighton Chad J, Lerner Seth P, Weinstein John N, Getz Gad, Kwiatkowski David J

Abstract excerpt

Invasive bladder cancer, for which there have been few therapeutic advances in the past 20 years, is a significant medical problem associated with metastatic disease and frequent mortality. Although previous studies had identified many genetic alterations in invasive bladder cancer, recent genome-wide studies have provided a more comprehensive view. Here, we review those recent findings and suggest therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Bladder and Urothelial Cancer Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenetics and DNA Methylation

Share to CTLA4 gene

Share to Genomics

Share to Mutation

Share to Signal Transduction

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 26473186
DOI: 10.1158/1078-0432.CCR-14-1215
PMCID: PMC4610178

Genes

CTLA4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise.PMID 26473186Read ↗

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Semantic proximity Read ↗

Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer.Semantic proximity Read ↗

Genetic and Epigenetic Alterations in Bladder CancerSemantic proximity Read ↗

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read ↗

Bladder Cancer in the Genomic EraSemantic proximity Read ↗

Advances in bladder cancer biology and therapy.Semantic proximity Read ↗

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets MeetSemantic proximity Read ↗

Comprehensive molecular characterization of urothelial bladder carcinomaSemantic proximity Read ↗

The evolution of bladder cancer genomics: What have we learned and how can we use it?Semantic proximity Read ↗

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune responseSemantic proximity Read ↗

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune responseSemantic proximity Read ↗

New discoveries in the molecular landscape of bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.